文献检索
文档翻译
深度研究
学术资讯

Zotero 插件

邀请有礼
套餐&价格
历史记录

应用&插件

Zotero 插件浏览器插件 Mac 客户端 Windows 客户端微信小程序

定价

高级版会员购买积分包购买API积分包

服务

文献检索文档翻译深度研究 API 文档 MCP 服务

关于我们

关于 Suppr 公司介绍联系我们用户协议隐私条款

关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究

粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

勘误：益气祛邪法治疗中晚期原发性肝癌的疗效及安全性的系统评价和Meta分析。

Corrigendum: The Therapeutic Principle of Combined Strengthening Qi and Eliminating Pathogens in Treating Middle-Advanced Primary Liver Cancer: A Systematic Review and Meta-Analysis.

作者信息

She Yingqi, Huang Qinfeng, Ye Zhen, Hu Yu, Wu Mingquan, Qin Kaihua, Wei Ailing, Yang Xin, Liu Yuyao, Zhang Cuihan, Ye Qiaobo

机构信息

School of Basic Medical Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu, China.

Department of Oncology, The First Affiliated Hospital, Guangxi University of Chinese Medicine, Nanning, China.

出版信息

Front Pharmacol. 2022 Feb 4;13:846668. doi: 10.3389/fphar.2022.846668. eCollection 2022.

DOI:10.3389/fphar.2022.846668

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8855032/

Abstract

[This corrects the article DOI: 10.3389/fphar2021.714287.].

摘要

[本文更正了文章的数字对象标识符：10.3389/fphar2021.714287。]

相似文献

1

Corrigendum: The Therapeutic Principle of Combined Strengthening Qi and Eliminating Pathogens in Treating Middle-Advanced Primary Liver Cancer: A Systematic Review and Meta-Analysis.勘误：益气祛邪法治疗中晚期原发性肝癌的疗效及安全性的系统评价和Meta分析。

Front Pharmacol. 2022 Feb 4;13:846668. doi: 10.3389/fphar.2022.846668. eCollection 2022.

2

The Therapeutic Principle of Combined Strengthening Qi and Eliminating Pathogens in Treating Middle-Advanced Primary Liver Cancer: A Systematic Review and Meta-Analysis.益气祛邪法治疗中晚期原发性肝癌的治疗原则：系统评价与Meta分析

Front Pharmacol. 2021 Oct 27;12:714287. doi: 10.3389/fphar.2021.714287. eCollection 2021.

3

[Meta-analysis of the efficacy of transcatheter arterial chemoembolization combined with percutaneous ethanol injection in treating unresectable primary liver cancer].经导管动脉化疗栓塞联合经皮乙醇注射治疗不可切除原发性肝癌疗效的Meta分析

Zhonghua Yi Xue Za Zhi. 2009 Mar 31;89(12):805-9.

4

[Analysis of Chinese medical syndrome features of patients with primary liver cancer before and after transcatheter arterial chemoembolization].[经导管动脉化疗栓塞术前后原发性肝癌患者中医证候特征分析]

Zhongguo Zhong Xi Yi Jie He Za Zhi. 2012 Sep;32(9):1171-4.

5

Transcatheter Arterial Chemoembolization Plus I-Labelled Metuximab versus Transcatheter Arterial Chemoembolization Alone in Intermediate/Advanced Stage Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.经导管动脉化疗栓塞联合¹³¹I标记美妥昔单抗与单纯经导管动脉化疗栓塞治疗中晚期肝细胞癌的系统评价和Meta分析

Korean J Radiol. 2016 Nov-Dec;17(6):882-892. doi: 10.3348/kjr.2016.17.6.882. Epub 2016 Oct 31.

6

Comparative efficacy and safety of Chinese herbal injections combined with transcatheter hepatic arterial chemoembolization in treatment of liver cancer: a bayesian network Meta-analysis.中药注射剂联合经导管肝动脉化疗栓塞治疗肝癌的疗效与安全性比较：贝叶斯网状 Meta 分析。

J Tradit Chin Med. 2020 Apr;40(2):167-187.

7

[Analysis of prescription regularity of traditional Chinese medicine for colorectal cancer based on data mining].基于数据挖掘的大肠癌中医用药规律分析

Zhongguo Zhong Yao Za Zhi. 2021 Aug;46(15):4016-4022. doi: 10.19540/j.cnki.cjcmm.20201127.501.

8

[Clinical evaluation of integration of transcatheter arterial chemoembolization and traditional Chinese medicine in treating metastatic liver cancer].经导管动脉化疗栓塞术联合中药治疗转移性肝癌的临床评估

Zhong Xi Yi Jie He Xue Bao. 2003 Sep;1(3):187-8, 233. doi: 10.3736/jcim20030312.

9

Drug effect analysis of sorafenib combined with transcatheter arterial chemoembolization in the treatment of advanced hepatocellular carcinoma.索拉非尼联合经动脉化疗栓塞术治疗晚期肝细胞癌的药物疗效分析

Pak J Pharm Sci. 2018 Jul;31(4(Special)):1751-1755.

10

Medicinals with properties of warming Yang and tonifying Qi in terms of Traditional Chinese Medicine: their effects on left ventricular ejection fraction and aldosterone in rats with induced failure heart.中医具有温阳益气功效的药物：对心力衰竭大鼠左心室射血分数及醛固酮的影响

J Tradit Chin Med. 2016 Dec;36(6):789-93. doi: 10.1016/s0254-6272(17)30016-x.